In contrast to its therapeutic efficacy against tumor-initiating (cancer stem) cells [45], inhibition of GSK-3β positively regulates the pluripotency of embryonic stem cells and the repopulation of hematopoietic stem cells via activation of the Wnt and hedgehog pathways, respectively [46, 47]. The gene discussed is GSK3B; the disease is cancer.